California Public Employees Retirement System Arcutis Biotherapeutics, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$24.42 - $34.75 $896,214 - $1.28 Million
-36,700 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$24.47 - $36.98 $95,530 - $144,369
-3,904 Reduced 9.61%
36,700 $1.06 Million
Q4 2020

Feb 02, 2021
SELL
$17.82 - $31.73 $4,936 - $8,789
-277 Reduced 0.68%
40,604 $1.14 Million
Q3 2020

Nov 05, 2020
BUY
$23.44 - $32.28 $466,104 - $641,887
19,885 Added 94.71%
40,881 $1.2 Million
Q2 2020

Aug 12, 2020
BUY
$24.48 - $36.56 $513,982 - $767,613
20,996 New
20,996 $635,000

Others Institutions Holding ARQT

# of Institutions
200
Shares Held
130M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $748M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email